False-positive results from CT colonography screening are considered an acceptable part of cancer detection for both patients and health care providers.
False-positives are something that must be taken in stride in order to detect more cancers say both patients and physicians, according to an article published in the journal Radiology.
Researchers from the United Kingdom wanted to determine if there was an acceptable maximum rate of false-positives from CT colonography for colorectal cancer screening.
A total of 52 patients and 50 health care professionals participated in the study. The patients had been scheduled to undergo unrelated ultrasounds. Both groups were asked to choose between unrestricted CT colonography that examined intra- and extracolonic organs or CT colonography restricted to the colon, across different scenarios. The disadvantages of the tests were explained to the patients.
“The first experiment detected one extracolonic malignancy per 600 cases with a false-positive rate varying across scenarios from 0 percent to 99.8 percent,” the authors wrote. “One experiment examined radiologic follow-up generated by false-positive diagnoses while the other examined invasive follow-up. Intracolonic performance was identical for both tests.”
The results showed that the median tipping point for radiologic follow-up occurred at a false-positive rate greater than 99.8% and participants would tolerate at least a 99.8% rate of unnecessary radiologic tests to detect an additional extracolonic malignancy.
Invasive follow-up had a lower median tipping point, occurring at a false-positive rate of 10%. Patients had significantly higher tipping points than did health care professionals for both experiments.
“Patients and health care professionals are willing to tolerate high rates of false-positive diagnoses with CT colonography in exchange for diagnosis of extracolonic malignancy,” the authors concluded.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.